These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 23369637)

  • 1. The promise of N-acetylcysteine in neuropsychiatry.
    Berk M; Malhi GS; Gray LJ; Dean OM
    Trends Pharmacol Sci; 2013 Mar; 34(3):167-77. PubMed ID: 23369637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-acetylcysteine in the treatment of psychiatric disorders: current status and future prospects.
    Minarini A; Ferrari S; Galletti M; Giambalvo N; Perrone D; Rioli G; Galeazzi GM
    Expert Opin Drug Metab Toxicol; 2017 Mar; 13(3):279-292. PubMed ID: 27766914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review.
    Deepmala ; Slattery J; Kumar N; Delhey L; Berk M; Dean O; Spielholz C; Frye R
    Neurosci Biobehav Rev; 2015 Aug; 55():294-321. PubMed ID: 25957927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action.
    Dean O; Giorlando F; Berk M
    J Psychiatry Neurosci; 2011 Mar; 36(2):78-86. PubMed ID: 21118657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Putative neuroprotective agents in neuropsychiatric disorders.
    Dodd S; Maes M; Anderson G; Dean OM; Moylan S; Berk M
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Apr; 42():135-45. PubMed ID: 23178231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview on the Effects of
    Tardiolo G; Bramanti P; Mazzon E
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30551603
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effectiveness of N-acetylcysteine in the treatment of schizophrenia].
    Miyake N; Miyamoto S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2016 Apr; 36(2):29-35. PubMed ID: 27333656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of acrolein-induced apoptosis by the antioxidant N-acetylcysteine.
    Tanel A; Averill-Bates DA
    J Pharmacol Exp Ther; 2007 Apr; 321(1):73-83. PubMed ID: 17204747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities.
    Bavarsad Shahripour R; Harrigan MR; Alexandrov AV
    Brain Behav; 2014 Mar; 4(2):108-22. PubMed ID: 24683506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perfusion magnetic resonance imaging in psychiatry.
    Théberge J
    Top Magn Reson Imaging; 2008 Apr; 19(2):111-30. PubMed ID: 19363433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chemistry and biological activities of N-acetylcysteine.
    Samuni Y; Goldstein S; Dean OM; Berk M
    Biochim Biophys Acta; 2013 Aug; 1830(8):4117-29. PubMed ID: 23618697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutathione: a novel treatment target in psychiatry.
    Berk M; Ng F; Dean O; Dodd S; Bush AI
    Trends Pharmacol Sci; 2008 Jul; 29(7):346-51. PubMed ID: 18538422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility.
    Dodd S; Dean O; Copolov DL; Malhi GS; Berk M
    Expert Opin Biol Ther; 2008 Dec; 8(12):1955-62. PubMed ID: 18990082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Acetylcysteine ethyl ester (NACET): a novel lipophilic cell-permeable cysteine derivative with an unusual pharmacokinetic feature and remarkable antioxidant potential.
    Giustarini D; Milzani A; Dalle-Donne I; Tsikas D; Rossi R
    Biochem Pharmacol; 2012 Dec; 84(11):1522-33. PubMed ID: 23000913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of N-acetylcysteine (NAC) on human cognition - A systematic review.
    Skvarc DR; Dean OM; Byrne LK; Gray L; Lane S; Lewis M; Fernandes BS; Berk M; Marriott A
    Neurosci Biobehav Rev; 2017 Jul; 78():44-56. PubMed ID: 28438466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-Acetylcysteine for the Treatment of Psychiatric Disorders: A Review of Current Evidence.
    Ooi SL; Green R; Pak SC
    Biomed Res Int; 2018; 2018():2469486. PubMed ID: 30426004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential role of N-acetylcysteine in the management of substance use disorders.
    McClure EA; Gipson CD; Malcolm RJ; Kalivas PW; Gray KM
    CNS Drugs; 2014 Feb; 28(2):95-106. PubMed ID: 24442756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of N-acetylcysteine on alcohol abstinence and alcohol-induced adverse effects in rats.
    Ferreira Seiva FR; Amauchi JF; Ribeiro Rocha KK; Souza GA; Ebaid GX; Burneiko RM; Novelli EL
    Alcohol; 2009 Mar; 43(2):127-35. PubMed ID: 19251114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-acetyl cysteine restores brain glutathione loss in combined 2-cyclohexene-1-one and d-amphetamine-treated rats: relevance to schizophrenia and bipolar disorder.
    Dean OM; van den Buuse M; Berk M; Copolov DL; Mavros C; Bush AI
    Neurosci Lett; 2011 Jul; 499(3):149-53. PubMed ID: 21621586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acetylcysteine prevents stress-induced anxiety behavior in zebrafish.
    Mocelin R; Herrmann AP; Marcon M; Rambo CL; Rohden A; Bevilaqua F; de Abreu MS; Zanatta L; Elisabetsky E; Barcellos LJ; Lara DR; Piato AL
    Pharmacol Biochem Behav; 2015 Dec; 139 Pt B():121-6. PubMed ID: 26261019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.